To further validate the positive relationship between the CD74‐202/CD74‐201 ratio and the enrichment of CD8+CXCL13+ Tex cells and C1QC+ TAMs, we performed the same SiT sequencing and analysis pipeline on 13 tumor samples extracted from 13 ESCC patients. The gene discussed is CD8A; the disease is neoplasm.